http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130037237-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04420713d8ca0e51f499cd44298a4692
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
filingDate 2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760a0dbf4e58545755958fa73910c13d
publicationDate 2013-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20130037237-A
titleOfInvention Use of Meloxycam for Long-Term Treatment of Musculoskeletal Disorders in Cats
abstract The present invention relates to the use of a formulation comprising Meloxycham, or a pharmacologically acceptable Meloxycham salt of an organic or inorganic base thereof, for the long term treatment of musculoskeletal disorders in a cat. No negative effects on kidney function occur after 10-20 months or more of treatment.
priorityDate 2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54677470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415136092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9685
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9685

Total number of triples: 24.